Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Qsymia
Marketing
FDA's promo police ding Vivus for misleading Qsymia webpage
In their second enforcement letter of 2019, the FDA's marketing overseers reprimanded Vivus for downplaying the risks of its weight loss drug Qsymia.
Beth Snyder Bulik
Jun 6, 2019 12:43pm
Eisai obesity drug Belviq picks up heart-safety edge
Jul 18, 2018 10:28am
Novo preps big obesity push, undeterred by its rivals' fates
Nov 21, 2017 11:57am
Chasing a payday, new drugmakers favor solo launches: report
Apr 17, 2017 11:22am
Orexigen puts Contrave at risk by stopping yet another heart study
Apr 14, 2016 10:09am
